Drug and Alcohol Testing Services for Employers
A drug testing program is only as strong as the chain of custody that protects it, the Medical Review Officer who reviews it, and the documentation that defends it when the result is challenged. When your drug testing is managed by a retail collection site with no occupational health infrastructure behind it, every confirmed positive is one procedural error away from being overturned – and every negative is one missed step away from being indefensible in a post-accident investigation.Â
Occucare International delivers physician-governed drug and alcohol testing for employers in Houston and across Texas – DOT-regulated and non-DOT programs designed for construction contractors, industrial manufacturers, fleet operators, energy companies, and defense contractors who need more than a specimen cup and a lab result. We manage the entire testing lifecycle: program design, policy development, specimen collection by DOT-certified collectors, SAMHSA-certified laboratory analysis, Medical Review Officer adjudication, Substance Abuse Professional coordination, and employer reporting with full chain-of-custody documentation – all under the same occupational health framework that governs our medical direction, injury management, and compliance testing programs.
Board-Certified MRO Physicians on Every Result
DOT & Non-DOT Programs Managed Separately
DOT-Certified Collection Sites
SAMHSA-Certified Laboratories
3,000+ Collection Network
Full Chain-of-Custody Documentation
Clinic Hours
- Monday - Friday 7:30 AM - 4:30 PM CST
- +1 713 802 0801
What Happens When Your Drug Testing Program Has Gaps - And Why Most Employers Do Not Know Until It Is Too Late
Drug testing failures rarely surface during routine operations. They surface during post-accident investigations, wrongful termination lawsuits, DOT audits, and general contractor compliance reviews – the moments when the quality of your testing program determines whether your company is protected or exposed. If any of the following describes your current drug testing infrastructure, your program has vulnerabilities that a structured occupational health testing program is designed to eliminate.
Who This Employer Drug Testing Program Is Built For
Occucare’s drug and alcohol testing program is designed for employers whose testing results are subject to legal scrutiny, regulatory audit, or general contractor compliance review — and for the decision-makers who own the exposure when a result is challenged.
- HR Directors and Compliance Leads administering drug-free workplace policies across DOT and non-DOT workforces
- Safety Directors and EHS Managers responsible for post-accident testing defensibility and reasonable suspicion protocol execution
- Designated Employer Representatives managing DOT random pool compliance, FMCSA Clearinghouse queries, and federal audit preparedness
- Fleet Managers and Transportation Supervisors overseeing CDL driver qualification files and DOT modal administration compliance
- Risk Managers and General Counsel evaluating chain-of-custody defensibility in wrongful termination and workers’ compensation exposure
Industries served: commercial and industrial construction, heavy civil contracting, fleet operations and CDL-regulated transportation, upstream/midstream/downstream energy, petrochemical processing, industrial manufacturing, Department of Defense contracting, and any employer operating under a drug-free workplace policy that needs testing results that hold up when challenged.
Chain-of-Custody Errors That Invalidate Results When You Need Them Most
The chain of custody is the unbroken documented trail from specimen collection through laboratory analysis and MRO review to final employer notification. Every step must be documented. Every handoff must be signed. Every timestamp must be recorded. When a retail collection site skips a signature, mislabels a specimen, or fails to document collector identification, the entire result becomes legally indefensible. A confirmed positive with a broken chain of custody cannot sustain a termination decision, cannot support a workers’ compensation defense, and cannot satisfy a DOT compliance audit. The test was performed. The money was spent. The result is worthless.
For construction employers managing post-accident testing – where specimen collection must occur within specific timeframes and the result may be introduced in a legal proceeding – a chain-of-custody error does not just invalidate a test. It removes your primary defense in a liability claim.
No Medical Review Officer - Or an MRO Who Has Never Seen a Workplace
The Medical Review Officer is the licensed physician who stands between the laboratory result and the employer notification. The MRO reviews every non-negative result, contacts the donor to evaluate legitimate medical explanations – prescription medications, medical conditions, procedural issues – and makes the clinical determination of whether the result should be reported as confirmed positive, negative, or cancelled.
When employers use testing vendors with no MRO, or with a third-party call center MRO who processes thousands of reviews per week with no occupational health context, two things happen. False positives from legitimate prescriptions are reported as confirmed positives, generating wrongful termination claims and legal exposure. And confirmed positives that should have been flagged are processed without the clinical scrutiny that catches inconsistencies in the donor’s explanation. The MRO is not a checkbox. It is the physician-level quality control that determines whether your drug test result will hold up when challenged.
Post-Accident Testing That Misses the Window - And Loses the Defense
When a workplace accident occurs and drug testing is required – either by DOT regulation, company policy, or project owner requirements – the testing window is measured in hours, not days. DOT regulations require drug testing as soon as practicable after an accident meeting specific criteria. Most employer policies and project specifications require testing within two to eight hours of the incident.
If your drug testing vendor cannot accommodate same-day collection, or if your onsite medical team does not have collection kits pre-staged and DOT-certified collectors available, the window closes. A post-accident drug test conducted outside the required timeframe is procedurally compromised. An employer who cannot produce a timely post-accident result faces the presumption that the test was avoided intentionally – a presumption that plaintiff’s attorneys and OSHA investigators exploit aggressively in post-incident proceedings.
Reasonable Suspicion Protocols That Create More Liability Than They Prevent
Reasonable suspicion drug testing is the highest-risk testing category for employers – because it is the only testing type initiated by a subjective observation rather than a regulatory trigger or a random selection algorithm. When a supervisor observes behavior consistent with impairment, the employer’s response must follow a documented, defensible protocol: trained supervisor observation, contemporaneous documentation of specific behavioral indicators, immediate removal from safety-sensitive duties, and prompt collection by a certified collector under full chain-of-custody procedures.
Without a defined reasonable suspicion protocol – and without supervisors trained to document observable behavioral indicators rather than subjective opinions – a reasonable suspicion test becomes a discrimination claim, a harassment allegation, or a wrongful termination lawsuit. The test result is irrelevant if the process that triggered it is legally indefensible. Occucare provides both the testing infrastructure and the supervisor training documentation that makes reasonable suspicion testing a risk mitigation tool instead of a liability generator.
DOT Compliance Gaps That Disqualify Drivers and Expose Employers to Federal Penalties
DOT-regulated drug and alcohol testing under 49 CFR Part 40 is not a suggestion. It is a federal requirement with specific procedural mandates that most general collection sites do not follow correctly. The DOT testing protocol requires specific chain-of-custody forms (not generic forms), split specimen collection, testing at SAMHSA-certified laboratories, MRO review following DOT-specific adjudication procedures, and Substance Abuse Professional evaluation and return-to-duty protocols for violations.
An employer whose DOT testing program does not follow 49 CFR Part 40 procedures exactly is operating non-compliant drivers – regardless of whether the test results are negative. During a DOT compliance audit or a post-accident investigation, procedural non-compliance is treated the same as a failed test: the driver is disqualified, the employer faces civil penalties, and the company’s DOT compliance record is flagged for enhanced scrutiny. For fleet operators and construction companies with CDL holders, DOT drug testing compliance is not about drug use. It is about program integrity.
Drug-Free Workplace Policies That Do Not Match Your Testing Program
Your drug-free workplace policy is the legal document that authorizes every drug test your company conducts. If the policy does not align with your testing protocols, your testing program operates outside its own authorization – creating legal exposure on every result. A policy that authorizes random testing for all employees but a program that only tests DOT-regulated positions creates a discrimination claim from any non-DOT employee who is randomly tested. A policy that references a 5-panel test but a program that runs a 10-panel creates challenges to results from the five substances not covered by the written policy.
Most employers have not reviewed their drug-free workplace policy since it was written. Most have never confirmed that the policy language matches the testing vendor’s actual procedures. This misalignment is invisible until a result is challenged – and at that point, the policy becomes the employer’s own evidence against them.
Employer Drug and Alcohol Testing in Occupational Health - Why It Is Not the Same as Retail Drug Screening
A drug test is a specimen. An employer drug testing program is a regulated system. The distinction matters because the test result is only as valuable as the system that produced it – the collection protocol, the laboratory certification, the MRO review, the chain-of-custody documentation, and the policy framework that authorizes the test in the first place.
Employer Drug and Alcohol Testing Defined
Employer drug and alcohol testing is the regulated collection, laboratory analysis, Medical Review Officer adjudication, and documented reporting of biological specimens to determine the presence of controlled substances or alcohol in employees or prospective employees under DOT or non-DOT regulatory frameworks.
In full context: DOT-regulated testing is governed by 49 CFR Part 40 for safety-sensitive transportation workers. Non-DOT testing is governed by employer policy, state law, and industry-specific requirements. In both frameworks, the program includes specimen collection by certified collectors, analysis at SAMHSA-certified laboratories, physician-level MRO review of all non-negative results, full chain-of-custody documentation, and employer notification through a Designated Employer Representative. The program is a compliance and risk management function managed for employers – not a clinical service delivered to patients.
DOT-Regulated Testing vs. Non-DOT Employer Testing - The Regulatory Distinction
These two testing frameworks share a common purpose but operate under fundamentally different regulatory structures. Conflating them – or running both under a single undifferentiated protocol – is one of the most common compliance failures in employer drug testing programs.
| Element | DOT-Regulated Testing | Non-DOT Employer Testing |
| Governing authority | 49 CFR Part 40 (federal) | Employer policy + state law |
| Testing panel | Standard 5-panel (SAMHSA-mandated) | Customizable: 5, 7, 10, 12-panel |
| Specimen type | Urine (oral fluid authorized 2023) | Urine, oral fluid, hair (per policy) |
| Chain-of-custody form | DOT-specific CCF (federal form) | Non-DOT CCF (provider form) |
| Split specimen | Required | Recommended, not required |
| MRO review | Required (DOT-specific procedures) | Best practice (employer discretion) |
| Laboratory certification | SAMHSA-certified (mandatory) | SAMHSA-certified (recommended) |
| Random testing rates | Federally mandated (50% drugs / 10% alcohol for FMCSA) | Employer-defined |
| Violation consequences | Federal: SAP evaluation, RTD testing, follow-up schedule | Per employer policy |
| Record retention | 5 years (federally mandated) | Per employer policy and state law |
Occucare manages DOT and non-DOT testing as separate, parallel programs – never combined, never conflated. Separate chain-of-custody forms, separate documentation, separate reporting protocols. When a DOT compliance auditor reviews your testing records, every DOT test is documented under DOT procedures. When a non-DOT result is challenged in an employment proceeding, the documentation reflects the employer’s policy authority, not federal regulation that does not apply.
Your drug testing program is either defensible when challenged or it isn’t.
Occucare’s Drug and Alcohol Testing Services - Every Testing Category Your Workforce Requires
Occucare administers every category of employer drug and alcohol testing under a single program with consistent collection protocols, certified collectors, SAMHSA-certified laboratory analysis, and physician-level MRO review applied to every specimen. Each testing category below serves a distinct regulatory or risk management function – and each requires specific procedural compliance to produce results that protect your operation.
01 - Pre-Employment Drug Testing
Pre-employment drug testing is the first compliance checkpoint for every new hire entering a safety-sensitive position. For DOT-regulated employers, it is a federal requirement: no employee may perform safety-sensitive functions until a verified negative drug test result is on file. For non-DOT employers in construction, manufacturing, and energy, it is the primary screening mechanism that prevents substance-impaired workers from accessing your job site or facility.
Occucare’s pre-employment testing program provides:
- Same-day scheduling at our Houston clinic – candidates tested and results reported within the timeframe your hiring process requires
- MRO review on every result – including negative results for DOT-regulated positions where verification is required before the employee can begin safety-sensitive work
- Multi-panel options for non-DOT testing – 5-panel standard, expanded 7, 10, or 12-panel including synthetic opioids, benzodiazepines, and barbiturates based on your policy requirements
For construction employers onboarding large crews for project mobilizations, Occucare provides batch pre-employment testing – processing multiple candidates in a single session with results delivered within the turnaround time your staffing schedule requires.
02 - Random Drug and Alcohol Testing
Random testing is the most effective deterrent against workplace substance use — and the most procedurally complex testing category to administer correctly. The deterrent value depends entirely on unpredictability, and unpredictability requires a properly managed random selection pool, scientifically random selection methods, and collection processes that prevent advance notice to selected employees.
Occucare manages the entire random testing process for DOT and non-DOT employer programs:
- Random pool management: We build and maintain your random selection pool, adding new hires and removing terminated employees as your workforce changes. For DOT-regulated employers, pool composition is maintained to meet FMCSA, PHMSA, or other modal administration requirements.
- Scientifically random selection: Selections are generated using computer-based random number algorithms that produce selections meeting DOT statistical randomness requirements. No manual selection, no pattern vulnerability.
- Selection rate compliance: DOT-mandated annual random testing rates are currently 50% for drugs and 10% for alcohol under FMCSA. Occucare manages selection frequency to ensure your annual rate is met by year-end, with quarterly rate tracking reported to your DER.
- Notification and scheduling: Selected employees are notified and scheduled for collection within the timeframes required by your program. Notification and collection documentation is maintained for audit purposes.
- Non-DOT random programs: For employers who want the deterrent effect of random testing without a federal mandate, Occucare designs and administers non-DOT random programs that operate under your company policy with the same procedural rigor applied to DOT testing.
03 - Post-Accident Drug and Alcohol Testing
Post-accident testing is the testing category with the narrowest execution window and the highest legal consequence when the window is missed. DOT regulations specify drug testing within 32 hours and alcohol testing within 8 hours of a qualifying accident. Many employer policies and project owner requirements impose shorter windows. The financial reality: a post-accident specimen collected outside the required window is procedurally compromised – and a plaintiff’s attorney will argue, successfully, that the missing test is evidence of concealment. The employer who cannot produce a timely, defensible post-accident result is not just missing a data point. They are handing the opposing party a narrative that shapes the entire post-incident proceeding.
Occucare’s post-accident testing infrastructure is designed for the urgency this testing category demands:
- Same-day scheduling at our Houston clinic – including walk-in availability for accident-day collection
- After-hours coordination – because workplace accidents do not observe business hours. Occucare coordinates specimen collection for incidents occurring outside standard clinic hours.
- Onsite collection capability – for employers with onsite medical personnel or pre-staged collection kits, Occucare’s DOT-certified collectors can deploy to the job site or facility for immediate collection
- Accident documentation coordination – post-accident testing documentation is coordinated with incident reporting to ensure the testing record aligns with the accident investigation timeline. This coordination is critical for workers’ compensation defense and OSHA post-incident documentation.
- Decision-point documentation – when a post-accident situation does not meet DOT testing thresholds, Occucare documents the decision not to test with the same rigor as the test itself. A documented non-testing decision based on DOT criteria is defensible. An undocumented decision not to test invites the assumption that testing was avoided.
04 - Reasonable Suspicion Drug and Alcohol Testing
- Supervisor training: Occucare provides reasonable suspicion training for supervisors and managers that covers the behavioral indicators that constitute reasonable suspicion, the documentation requirements for a defensible observation report, the distinction between reasonable suspicion and personal suspicion, the immediate actions required after a reasonable suspicion determination, and the legal boundaries that separate a compliant process from a discrimination claim. DOT-regulated employers are required to provide this training. Non-DOT employers should provide it for the same liability protection reasons.
- Immediate scheduling: When a supervisor makes a reasonable suspicion determination, time is critical. Occucare provides immediate scheduling for specimen collection – same day, same shift where possible – to preserve the temporal connection between the observation and the test.
- Documentation support: Occucare provides standardized reasonable suspicion observation forms that guide supervisors through the documentation of specific behavioral indicators. Proper documentation is the foundation of a legally defensible reasonable suspicion test.
05 - Return-to-Duty and Follow-Up Testing
When an employee violates your drug and alcohol policy – whether through a confirmed positive test, a refusal to test, or an alcohol concentration at or above the action level – the return-to-duty process determines whether and how that employee can resume safety-sensitive functions.
For DOT-regulated employees, the return-to-duty process is federally mandated under 49 CFR Part 40 Subpart O:
- Substance Abuse Professional (SAP) evaluation: The employee must be evaluated by a DOT-qualified SAP who determines the appropriate course of education or treatment. Occucare coordinates the SAP referral process and manages the documentation requirements.
- SAP follow-up report: After the employee completes the prescribed education or treatment, the SAP provides a follow-up report confirming compliance. This report is required before return-to-duty testing can be administered.
- Return-to-duty testing: A verified negative drug test result (and/or alcohol test below 0.02) under direct observation is required before the employee can return to safety-sensitive duties. Occucare administers the RTD test under DOT procedures with full documentation.
- Follow-up testing schedule: The SAP prescribes a follow-up testing plan — a minimum of six directly observed tests in the first 12 months, with the possibility of testing for up to 60 months. Occucare manages the follow-up schedule, administers all tests, and maintains the compliance record.
For non-DOT employees, Occucare manages the return-to-duty process according to your company’s drug-free workplace policy – coordinating any employer-required counseling, testing, and documentation requirements.
06 - Alcohol Testing
Alcohol testing operates under a different procedural framework than drug testing and requires separate handling, separate documentation, and – for DOT-regulated testing – specific equipment certifications and Breath Alcohol Technician (BAT) qualifications.
Occucare provides alcohol testing using both Evidential Breath Testing (EBT) devices and DOT-approved oral fluid or saliva alcohol testing methods. For DOT-regulated testing, only EBT devices listed on NHTSA’s Conforming Products List may be used for confirmation testing. Occucare’s alcohol testing program includes pre-employment alcohol testing where required by employer policy, reasonable suspicion alcohol testing with immediate same-day availability, post-accident alcohol testing within the DOT-mandated 8-hour window, random alcohol testing as part of DOT random pool management, and return-to-duty and follow-up alcohol testing under SAP-prescribed protocols.
Drug-Free Workplace Policies That Do Not Match Your Testing Program
Your drug-free workplace policy is the legal document that authorizes every drug test your company conducts. If the policy does not align with your testing protocols, your testing program operates outside its own authorization – creating legal exposure on every result. A policy that authorizes random testing for all employees but a program that only tests DOT-regulated positions creates a discrimination claim from any non-DOT employee who is randomly tested. A policy that references a 5-panel test but a program that runs a 10-panel creates challenges to results from the five substances not covered by the written policy.
Most employers have not reviewed their drug-free workplace policy since it was written. Most have never confirmed that the policy language matches the testing vendor’s actual procedures. This misalignment is invisible until a result is challenged – and at that point, the policy becomes the employer’s own evidence against them.
How Occucare’s Employer Drug Testing Program Works - From Program Design Through Ongoing Management
Step 1
Program Assessment and Policy Alignment
Before any testing is conducted, Occucare’s occupational health team assesses your current drug and alcohol testing program against your regulatory requirements, your company policy, and your operational needs. We identify gaps between your written policy and your actual testing procedures, evaluate whether your current vendor’s collection and documentation protocols meet DOT and best-practice standards, determine the appropriate testing panel, specimen type, and MRO review level for each workforce segment, and confirm that your Designated Employer Representative understands their role in the notification, scheduling, and result-receiving process.
Step 2
Policy Development or Update
If your drug-free workplace policy does not exist, does not align with your testing program, or has not been reviewed since it was written, Occucare assists in developing or updating the policy to ensure it authorizes every testing category your program requires, distinguishes between DOT-regulated and non-DOT employee populations, specifies the substances tested, the specimen types used, and the consequences of violations, complies with Texas state law, the Drug-Free Workplace Act (for federal contractors), and any project-specific owner requirements, and provides the legal foundation that makes every test result defensible.
Step 3
Specimen Collection
Every specimen is collected by DOT-certified collectors following 49 CFR Part 40 procedures for DOT tests and equivalent best-practice procedures for non-DOT tests. Collection occurs at our Houston clinic for walk-in and scheduled testing, onsite at your facility or job site for mobilization testing, post-accident collection, or large-volume testing events, or at any location in our 3,000+ clinic network for multi-site and multi-state operations. Chain-of-custody documentation begins at the moment of collection and is maintained through every subsequent step without interruption.
Step 4
Laboratory Analysis
All specimens are analyzed at SAMHSA-certified laboratories using immunoassay screening followed by gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) confirmation for non-negative specimens. SAMHSA laboratory certification is mandatory for DOT testing and the recognized standard for non-DOT employer programs. Occucare does not use non-certified laboratories for any employer drug testing.
Step 5
Medical Review Officer Adjudication
Every non-negative laboratory result is reviewed by Occucare’s Medical Review Officer – a board-certified physician specifically trained in substance abuse testing, DOT MRO procedures, and the clinical evaluation of donor-provided medical explanations. The MRO contacts the donor directly, evaluates any claimed prescription medications or medical conditions against clinical criteria, and makes the determination: confirmed positive, negative with medical explanation, or cancelled test. This physician-level review is what prevents false positives from becoming wrongful termination claims and ensures confirmed positives are documented to a standard that withstands legal scrutiny.
Step 6
Employer Reporting and Record Management
Verified results are reported to your Designated Employer Representative in the format your HR and safety teams require – clearance status, test type, collection date, and result, with full chain-of-custody records maintained in your employer compliance file. DOT testing records are retained for the federally mandated period. Non-DOT records are retained per your company policy and Texas state requirements. All records are maintained in audit-ready format accessible to your compliance team.
Drug and Alcohol Testing Across High-Regulation Employer Segments
Construction and General Contracting
Construction employers face drug testing requirements from three simultaneous sources: project owner specifications, general contractor subcontract requirements, and federal regulations for CDL-holding equipment operators. A single construction company may need pre-employment testing for all new hires under the company’s drug-free workplace policy, DOT random testing for CDL-holding crane operators and commercial drivers, reasonable suspicion and post-accident testing under both DOT and non-DOT protocols, and compliance documentation that satisfies the GC’s audit requirements for every worker on the project. Occucare manages all four testing streams under one program with unified documentation — so your compliance file is complete when the GC’s safety officer requests it, not assembled after the fact.
Fleet Operations and DOT-Regulated Transportation
Employers with CDL-holding drivers operating under FMCSA regulations face the most prescriptive drug testing requirements of any industry. Pre-employment, random, reasonable suspicion, post-accident, return-to-duty, and follow-up testing are all federally mandated with specific procedural requirements that vary by DOT modal administration. Occucare manages FMCSA, PHMSA, FAA, FRA, and FTA drug and alcohol testing programs with full regulatory compliance, consolidated reporting for multi-driver fleets, and FMCSA Drug and Alcohol Clearinghouse query coordination.
Oil and Gas and Energy Operations
Energy employers operating refineries, pipelines, and chemical processing facilities face drug testing requirements that intersect DOT pipeline safety regulations (PHMSA), project owner specifications, and contractor management programs. Occucare supports energy employers with testing programs that address DOT-regulated pipeline workers, non-DOT refinery and plant operations workers, contractor onboarding testing for owner-operator facilities, and rapid post-accident testing for remote and offshore locations through our clinic network.
Department of Defense Contractors
DoD contractors are subject to the Drug-Free Workplace Act and, depending on the contract, additional testing requirements specified by contracting agencies. Occucare’s DoD testing program manages both federal contractor drug-free workplace requirements and project-specific testing mandates - with documentation formatted to meet government audit standards.
Manufacturing and Industrial Operations
Manufacturing employers managing drug testing across shifts, facilities, and employee populations need standardized testing protocols that produce consistent results regardless of location. Occucare’s manufacturing drug testing program provides pre-employment testing integrated with the hiring workflow, random testing pools managed across multiple facilities, post-accident and reasonable suspicion testing with same-day availability, and centralized reporting that gives your corporate safety team visibility across all locations.
Retail Collection Vendor vs. Occucare's Physician-Governed Testing Program
| Factor | Retail Collection Vendor | Occucare Managed Program |
| MRO review on non-DOT results | Optional, often absent or via third-party call center | Board-certified occupational medicine MRO on every non-negative |
| DOT and non-DOT program separation | Combined or conflated | Managed as parallel compliant programs |
| Chain-of-custody documentation | Varies by collector training | Standardized 49 CFR Part 40 procedure, every specimen |
| Post-accident availability | Business hours, appointment-based | Same-day, after-hours, onsite deployment |
| Reasonable suspicion protocol support | None | Supervisor training, documentation forms, immediate collection |
| DOT random pool management | Employer manages via spreadsheet | Occucare manages selection, notification, scheduling, rate tracking |
| Drug-free workplace policy alignment | Out of scope | Policy review and update included in program design |
| Integration with injury management program | None | Unified physician governance across testing and injury case management |
| Multi-site consistency | Varies by location | 3,000+ clinic network with standardized protocols |
| Employer reporting format | Clinical reports | Employer-formatted: DER-routable, audit-ready |
The Financial Case for Physician-Governed Drug Testing Under an Occupational Health Program
The Cost of a Failed Drug Test Is Not the Test - It Is the Cascade
A pre-employment drug test costs a fraction of a single day’s wages. The cost of not testing – or of testing with a program that produces indefensible results – is measured in incident costs, legal exposure, and insurance premium trajectory.
An impaired worker who passes a deficient pre-employment screen and subsequently causes a workplace accident generates workers’ compensation claim costs, potential third-party liability exposure, OSHA investigation and potential citation, Experience Modification Rate elevation for up to 36 months, project owner relationship damage, and the operational cost of the incident itself. The employer’s first question in the post-incident investigation will be whether a drug test was conducted and whether it was defensible. If the answer to either question is no, the employer’s liability exposure multiplies.
Two-Scenario Cost Comparison: Retail Collection Site vs. Physician-Governed Testing Program
| Factor | Scenario A: Retail Collection Vendor | Scenario B: Occucare Managed Program |
| Workforce | 200 employees, 40 CDL-holding drivers, construction GC | 200 employees, 40 CDL-holding drivers, construction GC |
| Post-accident test collected within DOT window | 60% of incidents (window missed on 40%) | 100% of incidents – same-day and after-hours coordination |
| MRO review on non-DOT results | Inconsistent or absent | 100% – board-certified occupational medicine MRO |
| Chain-of-custody defensibility in wrongful termination challenge | Variable – depends on collection site procedures | Defensible – documented at every handoff |
| DOT random pool rate compliance | Managed in-house by HR via spreadsheet | Managed by Occucare – FMCSA rates met by year-end |
| DOT audit exposure per violation | Up to $16,131 per violation, compounding | $0 – procedural compliance maintained continuously |
| Wrongful termination exposure from challenged positive | High – indefensible chain of custody | Low – MRO-adjudicated, documented to DOT-equivalent standard |
| Annual managed program cost | – | Fraction of a single DOT audit penalty or wrongful termination settlement |
The cost comparison is not per-test pricing. It is the gap between indefensible results and defensible ones – measured in litigation outcomes, not collection fees.
Wrongful Termination Exposure From Indefensible Results
A confirmed positive drug test that is challenged in an employment proceeding requires defensible chain-of-custody documentation, a properly credentialed MRO review with documented donor interview, collection by a certified collector following applicable procedures, analysis at a SAMHSA-certified laboratory, and a written policy that authorizes the test and specifies the consequences. If any element is missing, the termination decision based on that result is legally vulnerable. The cost of a wrongful termination claim – settlement, legal fees, administrative burden – dwarfs the cost difference between a physician-governed testing program and a retail collection site with no MRO infrastructure.
DOT Non-Compliance Penalties
DOT civil penalties for drug and alcohol testing violations can exceed $16,000 per violation for employers and $5,000 per violation for individuals. Violations include operating a driver who has not completed required testing, failing to administer post-accident testing within required timeframes, using non-certified collectors or laboratories, failing to maintain required testing records, and not registering with or reporting to the FMCSA Drug and Alcohol Clearinghouse. A single DOT compliance audit that identifies systematic procedural failures across your testing program can produce penalty exposure that exceeds the entire annual cost of a properly managed program.
Why Occucare - Physician-Governed Drug Testing, Not Retail Collection
The difference between Occucare’s drug testing program and a retail collection site is not the specimen. It is everything that happens before, during, and after the specimen is collected.
Board-certified MRO physicians reviewing every result
Not a third-party call center processing reviews in volume. Occucare’s MRO physicians are board-certified occupational medicine physicians who understand the clinical, regulatory, and employment context of every result they adjudicate.
DOT and non-DOT managed as separate, compliant programs
Never combined, never conflated. Separate chain-of-custody forms, separate documentation, separate reporting protocols. Your DOT compliance audit and your non-DOT employment proceedings each reference the correct regulatory framework.
Same-day and after-hours testing for post-accident and reasonable suspicion
Because testing windows are measured in hours. Occucare’s Houston clinic and onsite collection capability ensure specimens are collected within required timeframes.
Complete random pool management
Selection, notification, scheduling, collection, and rate tracking - handled by Occucare so your HR team is not managing a federally regulated random testing process on spreadsheets.
Drug-free workplace policy alignment
Every testing category your program administers is authorized by your written policy. Occucare reviews and assists in updating policies to eliminate the misalignment that creates legal exposure.
3,000+ clinic network
For multi-site and multi-state employers who need consistent testing protocols, certified collection, and centralized reporting regardless of where their workforce operates.
Integrated with your occupational health program
Drug testing at Occucare is not an isolated transaction. It connects to the same physician governance framework that oversees your compliance testing, injury management, and medical direction programs. When a post-accident drug test is conducted, the result is coordinated with the injury case management team handling the workers’ compensation claim. One system. One clinical team. One documentation record.
Frequently Asked Questions - Employer Drug and Alcohol Testing
DOT testing uses the standard 5-panel test mandated by SAMHSA and 49 CFR Part 40: marijuana (THC), cocaine, amphetamines/methamphetamines, opioids (codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, 6-AM/heroin), and phencyclidine (PCP). Non-DOT testing allows employers to customize panels based on company policy and industry requirements. Common non-DOT panels include 7-panel (adding benzodiazepines and barbiturates), 10-panel (adding methadone, propoxyphene, and methaqualone), and expanded panels including synthetic opioids (fentanyl), MDMA, and other substances. Occucare administers all panel configurations with SAMHSA-certified laboratory analysis.
Occucare provides same-day post-accident testing at our Houston clinic, including walk-in availability during business hours and after-hours coordination for incidents occurring outside standard hours. For employers with onsite medical personnel, Occucare pre-stages collection kits and provides certified collector availability for immediate onsite collection. DOT regulations require drug testing within 32 hours of a qualifying accident and alcohol testing within 8 hours. Occucare’s infrastructure is designed to collect specimens well within these windows.
Yes. Occucare manages the complete DOT random testing process: building and maintaining the random selection pool, generating scientifically random selections at the frequency required to meet annual rate mandates, notifying selected employees, scheduling and administering collections, processing results through MRO review, and providing quarterly rate tracking reports to your Designated Employer Representative. Current FMCSA annual random testing rates are 50% for drugs and 10% for alcohol. Occucare manages selection frequency to ensure compliance by year-end.
A Medical Review Officer is a licensed physician with specialized training in drug and alcohol testing who reviews all non-negative laboratory results before they are reported to the employer. The MRO contacts the donor to evaluate legitimate medical explanations - prescription medications, medical conditions, procedural concerns - and makes the clinical determination of whether the result is a confirmed positive, a verified negative with medical explanation, or a cancelled test. For DOT testing, MRO review is federally mandated. For non-DOT testing, MRO review is the best practice that prevents false positive results from generating wrongful termination claims, ensures confirmed positive results are documented to a standard that withstands legal challenge, and provides the physician-level clinical judgment that a laboratory report alone cannot deliver. Occucare’s MRO physicians are board-certified occupational medicine physicians - not third-party review services processing results without clinical context.
Yes. Occucare assists employers in developing new drug-free workplace policies and updating existing policies to ensure alignment with your testing program, DOT regulatory requirements, Texas state law, the Drug-Free Workplace Act for federal contractors, and project-specific owner requirements. Policy alignment is not optional - it is the legal foundation that authorizes every test your program conducts and specifies the consequences that make your testing results actionable.
The Program Assessment is a structured evaluation of your current drug and alcohol testing infrastructure conducted by Occucare's occupational health team before any testing agreement is scheduled. The assessment reviews your current drug-free workplace policy against your actual testing procedures, evaluates your collection vendor's chain-of-custody protocols and MRO arrangements, audits your DOT random pool composition and rate compliance, examines your post-accident and reasonable suspicion documentation and response times, and confirms your Designated Employer Representative processes meet federal requirements. You receive a documented gap report identifying every area where your program exposes the company to legal, regulatory, or operational risk - along with a recommended policy update, protocol redesign, and transition plan to move your testing program under physician governance. The assessment is the diagnostic that determines whether your current results will hold up when challenged in a DOT audit, a post-incident investigation, or a wrongful termination proceeding.
Drug testing at Occucare is one component of an integrated occupational health program governed by the same board-certified physicians who oversee corporate medical direction, workplace injury management, and compliance testing. When a post-accident drug test is administered, the MRO review is coordinated with the case management team handling the injury claim. When a pre-employment drug test is conducted alongside a DOT physical or pre-employment physical, the results are managed under a single compliance file. When a reasonable suspicion test is triggered on a job site with Occucare onsite medical personnel, the collection and documentation are coordinated through the same clinical team. This integration eliminates the gaps between drug testing and your broader occupational health infrastructure that create documentation failures and coordination breakdowns in fragmented vendor models.
Explore Related Occucare Services
Workplace Compliance Testing Hub
The complete employer compliance testing program: drug testing, respirator fit, PFT, cognitive screening, and surveillance monitoring under one provider.
DOT Physicals
FMCSA-certified DOT physical examinations for commercial motor vehicle operators. Often paired with DOT drug testing as part of driver compliance onboarding.
Pre-Employment Physicals
Pre-hire physical examinations and fitness evaluations for construction, industrial, and safety-sensitive positions. Paired with pre-employment drug testing for comprehensive onboarding clearance.
Corporate Medical Direction
The physician governance framework overseeing your drug testing, compliance testing, and injury management programs.
Occupational Health Clinic Houston
Walk-in and scheduled drug testing, compliance testing, and workplace injury care at our Houston facility.
Build a Drug Testing Program That Protects Your Operation - Not Just Checks a Box
Your drug testing program is either a risk management system that produces defensible results under physician governance – or it is a collection of specimens processed through retail infrastructure that will not hold up when challenged. Occucare International delivers the former: DOT and non-DOT drug and alcohol testing with certified collection, SAMHSA-certified laboratory analysis, board-certified MRO adjudication, and full chain-of-custody documentation – integrated with the occupational health program that governs your compliance testing, injury management, and medical direction.